Ajai K, Panat
SR, Aggarwal A, Agarwal N, Upadhyay N, Joshi A. Estimation of serum lipids in patients
with Oral Submucous Fibrosis in India. J Clin Exp Dent. 2014;6(3):e237-42.
doi:10.4317/jced.51327
References
1. Rajalalitha
P, Vali S. Molecular pathogenesis of oral submucous fibrosis − a collagen metabolic disorder. J
Oral Pathol Med. 2005;34:321-8.
http://dx.doi.org/10.1111/j.1600-0714.2005.00325.x
PMid:15946178
2. Kumar P, Augustine J, Urs AB, Arora S, Gupta S, Mohanty VR. Serum lipid profile in oral cancer and leukoplakia: correlation with tobacco abuse and
histological grading. J Cancer Res Ther.
2012;8:384-8.
http://dx.doi.org/10.4103/0973-1482.103517
PMid:23174719
3. Lohe
VK, Degwekar SS, Bhowate
RR, Kadu RP, Dangore SB.
Evaluation of correlation of serum lipid profile and its association with
tobacco abuse. J Oral Pathol Med. 2010;39:141-8.
http://dx.doi.org/10.1111/j.1600-0714.2009.00828.x
PMid:20002982
4. Mehrotra
R, Pandya S, Chaudhary AK,
Kumar M, Singh M. Prevalence of oral premalignant and malignant lesions at a
tertiary level hospital in Allahabad, India. Asian Pac J Cancer Prev. 2008;9:263-5.
PMid:18712970
5. Murti
PR, Bhonsle RB, Pindborg
JJ, Daftary DK, Gupta PC, Mehta FS. Malignant transformation rate in oral submucous
fibrosis over a 17-year period. Community Dent Oral Epidemiol. 1985;13:340-1.
http://dx.doi.org/10.1111/j.1600-0528.1985.tb00468.x
PMid:3866655
6. Chawda
JG, Jain SS, Patel HR, Chaduvula N, Patel K. The relationship between serum lipid levels and the risk of oral
cancer. Indian J Med Paediatr
Oncol. 2011;32:34-7.
http://dx.doi.org/10.4103/0971-5851.81888
PMid:21731214
PMCid:PMC3124988
7. Schatzkin
A, Hoover RN, Taylor PR, Ziegler RG, Carter CL, Albanes
D, et al. Site-specific analysis of total serum cholesterol and incident cancer
in the National Health and Nutrition Examination Survey I Epidemiologic
Follow-up Study. Cancer Res. 1988;48:452-8.
PMid:3335013
8. Halton
JM, Nazir DJ, McQueen MJ, Barr RD. Blood lipid
profiles in children with acute lymphoblastic leukemia. Cancer.
1998;83:379-84.
http://dx.doi.org/10.1002/(SICI)1097-0142(19980715)83:2<379::AID-CNCR24>3.0.CO;2-P
PMid:9669823
9. Simό Camps E, Ortí Llavería
A, Sena Ferrer F, Contreras
Barbeta E. Blood cholesterol in patients with cancer.
An Med Interna. 1998;15:363-6.
PMid:9710986
10. Allampallam
K, Dutt D, Nair C, Shetty
V, Mundle S, Lisak L, et
al. The clinical and biologic significance of abnormal lipid profiles in
patients with myelodysplastic syndromes. J Hematother Stem Cell Res. 2000;9:247-55.
http://dx.doi.org/10.1089/152581600319469
PMid:10813538
11. Gerber M, Richardson S, Crastes de Paulet P, Pujol H, Crastes de Paulet A. Relationship between vitamin E and
polyunsaturated fatty acids in breast cancer: Nutritional and metabolic
aspects. Cancer. 1989;64:2347-53.
http://dx.doi.org/10.1002/1097-0142(19891201)64:11<2347::AID-CNCR2820641126>3.0.CO;2-V
PMid:2804926
12. Gerber M, Cavallo F, Marubini E, Richardson
S, Barbieri A, Capitelli E,
et al. Liposoluble vitamins and lipid parameters in
breast cancer. A joint study in northern Italy and southern
France. Int J Cancer. 1988;42:489-94.
http://dx.doi.org/10.1002/ijc.2910420403
PMid:3170022
13. Forones
NM, Falcao JB, Mattos D, Barone B. Cholesterolemia in
colorectal cancer. Hepatogastroenterology. 1998;45:1531-4.
PMid:9840100
14. Elmehdawi
R. Hypolipidemia: a word of caution. Libyan J Med.
2008;3:84-90.
http://dx.doi.org/10.4176/071221
PMid:21499464
PMCid:PMC3074286
15. Ames BN. Dietary
carcinogens and anticarcinogens: Oxygen radicals and
degenerative diseases. Science. 1983;221:1256-64.
http://dx.doi.org/10.1126/science.6351251
PMid:6351251
16. Patel PS, Shah MH, Jha FP, Raval GN, Rawal RM, Patel MM, et al. Alterations in plasma lipid
profile patterns in head and neck cancer and oral precancerous conditions. Indian J Cancer. 2004;41:25-31.
PMid:15105576
17. Rose G, Shipley MJ. Plasma
lipids and mortality: a source of error. Lancet. 1980;1:523-6.
http://dx.doi.org/10.1016/S0140-6736(80)92775-0
PMid:6102243
18. Alexopoulos
CG, Blatsios B, Avgerinos A. Serum lipids and
lipoprotein disorders in cancer patients. Cancer. 1987;60:3065-70.
http://dx.doi.org/10.1002/1097-0142(19871215)60:12<3065::AID-CNCR2820601234>3.0.CO;2-Q
PMid:3677028
19. Haider
SM, Merchant AT, Fikree FF, Rahbar
MH. Clinical and functional staging of oral submucous fibrosis. Br J Oral Maxillofac
Surg. 2000;38:12-5.
http://dx.doi.org/10.1054/bjom.1999.0062
PMid:10783440
20. Aggarwal
A, Shetti A, Keluskar V, Bagewadi A. Estimation of serum beta carotene levels in
patients with oral submucous fibrosis in India. J
Oral Sci. 2011;53:427-31.
http://dx.doi.org/10.2334/josnusd.53.427
PMid:22167026
21. Mehrotra
R, Pandya S, Chaudhary AK,
Singh HP, Jaiswal RK, Singh M, et al. Lipid profile
in oral submucous fibrosis. Lipids Health Dis. 2009;8:29.
http://dx.doi.org/10.1186/1476-511X-8-29
PMid:19630946
PMCid:PMC2721834
22. Tilakaratne
WM, Klinikowski MF, Saku T,
Peters TJ, Warnakulasuriya
S. Oral submucous fibrosis: review on aetiology and pathogenesis. Oral Oncol. 2006;42:561-8.
http://dx.doi.org/10.1016/j.oraloncology.2005.08.005
PMid:16311067